We are live on ! Find out more
NEO icon

NeoGenomics

132 hedge funds and large institutions have $604M invested in NeoGenomics in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 43 increasing their positions, 50 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital inflows, than outflows

Capital inflows: $55.8M | Capital outflows: $49.1M

0.23% more ownership

Funds ownership: 84.52% → 84.75% (+0.23%)

5% less funds holding

Funds holding: 139 → 132 (-7)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

14% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 50

35% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 20

Holders
132
Holders Change
-7
Holders Change %
-5.04%
% of All Funds
2.99%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.16%
New
13
Increased
43
Reduced
50
Closed
20
Calls
$814K
Puts
–
Net Calls
+$814K
Net Calls Change
-$836K

NEO Hedge Fund Activity: Q4 2017 in Review

132 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2017, worth a combined $604M — down 19% from $743M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of NEO and 13 opened new positions — a net loss of 7 holders — while 50 trimmed existing stakes and 43 added.

The largest buyer was Janus Henderson Group, adding an estimated $19.5M. The largest seller was Next Century Growth Investors, cutting an estimated $8.35M.

  • 132 institutional investors held NeoGenomics (NEO) as of Q4 2017, down from 139 in Q3 2017.
  • Funds reported $604M of NeoGenomics stock for Q4 2017, down 19% quarter-over-quarter.
  • 13 funds opened new NeoGenomics positions in Q4 2017 and 20 closed out, a net change of -7 holders.
  • The largest NeoGenomics buyer in Q4 2017 was Janus Henderson Group, an estimated $19.5M added.
  • The largest NeoGenomics seller in Q4 2017 was Next Century Growth Investors, an estimated $8.35M sold.

Based on aggregated 13F filings for Q4 2017.